GENT — Gentian Diagnostics ASA Cashflow Statement
0.000.00%
Last trade - 00:00- NOK842.06m
- NOK764.97m
- NOK152.07m
- 47
- 12
- 70
- 34
Annual cashflow statement for Gentian Diagnostics ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -17.5 | -24.8 | -23.6 | -10.6 | 20.1 |
| Depreciation | |||||
| Non-Cash Items | 3.28 | 4.63 | 3.35 | 8.62 | 2.58 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.95 | -14.2 | -3.93 | 7.92 | -18.1 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -12.5 | -27.1 | -14 | 15.5 | 13.5 |
| Capital Expenditures | -6.47 | -12.8 | -14.7 | -4.49 | -10.9 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 6.74 | 0 | 0 | -0.39 | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 0.274 | -12.8 | -14.7 | -4.88 | -10.9 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.51 | -3.12 | -4.33 | -4.6 | -4.95 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -13.6 | -43 | -33.3 | 6.04 | -2.9 |